Chapter 8. Neuroleptic Malignant Syndrome

  1. Stewart A. Factor DO1,
  2. Anthony E. Lang MD2 and
  3. William J. Weiner MD3
  1. Stewart A. Factor

Published Online: 14 JAN 2008

DOI: 10.1002/9780470753217.ch8

Drug Induced Movement Disorders, Second Edition

Drug Induced Movement Disorders, Second Edition

How to Cite

Factor, S. A. (2005) Neuroleptic Malignant Syndrome, in Drug Induced Movement Disorders, Second Edition (eds S. A. Factor, A. E. Lang and W. J. Weiner), Blackwell Publishing Inc., Malden, Massachusetts, USA. doi: 10.1002/9780470753217.ch8

Editor Information

  1. 1

    Movement Disorders Center, Department of Neurology, Emory University, Atlanta, USA

  2. 2

    Movement Disorders Clinic, Toronto Western Hospital, Toronto, Canada

  3. 3

    Department of Neurology, University of Maryland School of Medicine, Baltimore, USA

Publication History

  1. Published Online: 14 JAN 2008
  2. Published Print: 1 JAN 2005

ISBN Information

Print ISBN: 9781405126199

Online ISBN: 9780470753217

SEARCH

Keywords:

  • malignant syndrome;
  • chemotherapy;
  • dyspnea;
  • dyskinesias;
  • tetrabenazine

Summary

This chapter contains section titled:

  • History

  • Clinical aspects

  • Diagnosis

  • Course and complications

  • Situations resulting in NMS

  • Differential diagnosis

  • Epidemiology

  • Pathogenesis and pathology

  • Risk factors

  • Treatment

  • Future consideration

  • Acknowledgments